Clinicopathological characteristics of follicular dendritic cell sarcoma:an analysis of 23 cases
10.13315/j.cnki.cjcep.2025.08.007
- VernacularTitle:滤泡树突细胞肉瘤23例临床病理分析
- Author:
Xingxing WANG
1
;
Dongxian JIANG
1
;
Wei YUAN
1
;
Xiaolei ZHANG
1
;
Feng GAO
1
;
Yingyong HOU
1
Author Information
1. 复旦大学附属中山医院病理科,上海 200032
- Publication Type:Journal Article
- Keywords:
follicular dendritic cell sarcoma;
EBER;
diagnosis;
prognosis
- From:
Chinese Journal of Clinical and Experimental Pathology
2025;41(8):1017-1023
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To investigate the clinicopathological features and prognostic factors of follicular dendritic cell carcinoma(FDCS).Methods Hospital records of 23 patients diagnosed with FDCS were retrospectively re-viewed.The morphological,immunohistochemical features,including the detection of CD21,CD23,and CD35 using the EnVision method,and in-situ hybridization for Epstein-Barr virus encoded nuclear RNA(EBER)were evaluated.Clinicopathological characteristics were analyzed for the evaluation of prognosis.Results The median age of all 23 pa-tients was 50 years(range:27 to 72)and the female to male ratio was 1.3.The median maximum diameter of tumor was 7.0 cm(range:0.5 to 20.0 cm).One case was located in cervical lymph node,while another 22 were discovered in extranodal sites.20 cases were single organ and 3 cases were multiple organs involvement.Microscopically,tumor cells exhibited spindle,oval,or markedly pleomorphic morphology,accompanied by variable lymphoplasmacytic infil-tration in the stroma.CD21,CD35 and CD23 were positive in 22 of 23(95.6%),23 of 23(100.0%)and 4 of 15(26.7%)patients,respectively.EBER in-situ hybridization was positive in 9 of 23 patients(39.1%).The median follow-up time was 84.0(95%CI:50.7-117.3)months,and the 5-year survival rate was 80.2%(95%CI:62.8-97.6).Twelve(52.2%)patients were alive,5(21.7%)were dead,and 6(26.1%)were lost of follow-up.We es-tablished a pathological scoring system containing 5 indexes,i.e.,tumor maximum diameter,mitotic figures,tumor necrosis,cellular pleomorphism and histologic types.Patients with greater than 4 points had a significant poor progno-sis.Conclusion FDCS features a broad spectrum of histologic appearances and behavior.Combined morphological observations(HE staining),applications of a panel of follicular dendritic cell markers and EBER in-situ hybridization are helpful for accurate diagnosis.FDCS poses risks for recurrence,metastasis and death,and those with greater than 4 points in the scoring system have a significant poor prognosis.Long-term follow up is needed.